ZYDUS WELLNESS LTD.-$ - 531335 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of loss of share certificate under Regulation 39(3) of the SEBI (LODR) Regulations, 201527-12-2023
27-12-2023
Zydus Arm Gets Rs 284 Crore Tax Demand
ZHL expects the tax demand to have no material financial impact and has already disagreed to the demand on the e-filing portal of the department, it said.26-12-2023
ZYDUS WELLNESS LTD.-$ - 531335 - Receipt Of Assessment Order Of VAT
Receipt of Assessment Order of VAT21-12-2023
Zydus Life hits 52-week high on permission and approval from USFDA
The product will be manufactured at the group's formulation manufacturing facility in Moraiya, Ahmedabad (India).18-12-2023
ZYDUS WELLNESS LTD.-$ - 531335 - Judgement Of Hon''ble Supreme Court Of India In The Matter Of Usage Of Trademark "Sugarlite"
Judgement of Hon''ble Supreme Court of India in the matter of usage of Trademark "Sugarlite"17-12-2023
Zydus Lifesciences stock rises after securing approval for Darunavir tablets
Zydus Lifesciences receives approval from USFDA for Darunavir Tablets in 600 mg and 800 mg strengths15-12-2023
Zydus secures USFDA approval for Cyclophosphamide Capsules, shares up
The shares of Zydus Lifesciences were up by 0.93 per cent to 643.00 at 2:26 pm on the BSE14-12-2023
ZYDUS WELLNESS LTD.-$ - 531335 - Receipt Of Assessment Order Of VAT And CST
Receipt of Assessment order of VAT and CST12-12-2023
Zydus Lifesciences inks licensing pact with Daewoong Pharmaceutical
Zydus Worldwide DMCC, a wholly-owned subsidiary, and Daewoong Pharmaceutical Co Ltd have entered into an exclusive licensing agreement to co-develop and commercialise Leuprolide Acetate for depot suspension in six dosage strengths for the US market, Zydus Lifesciences said in a regulatory filing.11-12-2023